Virbac (VRBCF) has bolstered its specialty pet health portfolio by acquiring a world-leading feline hyperthyroidism treatment ...
Geneticist Michael Klotsman was frustrated by human drug development. That led him to launch a startup focused on treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback